Displaying drugs 14676 - 14700 of 14958 in total
R450
R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational
2-Cyclopropylmethylenepropanal
Experimental
Methoxyamine
Investigational
Pentanal
Pentanal is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. This drug targets the protein cAMP-dependent protein kinase catalytic subunit alpha.
Experimental
Undecanal
Experimental
Trichloroacetaldehyde
Experimental
PROPYL-1-PHOSPHATE
Experimental
Antimonous acid
Experimental
Methylphosphinic Acid
Experimental
R-348
Investigational
FavId
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational
Lactaldehyde
Experimental
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
KB002
KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Investigational
UC-781
UC-781 is a thiocarboxanilide non-nucleoside reverse transcriptase inhibitor (NNRTI). It is a topical microbicide targeted against the AIDS virus.
Investigational
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
Lauroyl chloride
Experimental
Betaine aldehyde
Experimental
ISIS 113715
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant
reductions in LDL-cholesterol.
Investigational
1-Amino-1-Carbonyl Pentane
Experimental
Acetophenone
Experimental
Displaying drugs 14676 - 14700 of 14958 in total